Brightplex® is a customizable solution using chromogenic multiplex IHC and image analysis on a single slide allowing multiple biomarkers phenotyping and quantification within the tumor microenvironnment.
One of the biggest challenges in immunotherapy area is to find accurately which patients will benefit from this new treatment. To help drug developers getting this information, the assessment of biomarkers through clinical research studies represent a key step.
During this seminar, you will learn about HalioDx innovative Brightplex® platform combined with high level immuno-oncology expertise, providing to biotech and pharma partners a unique solution to get meaningful and actionable data through biomarker testing.
Presented by :
Jacques Fieschi , VP, R&D of HalioDx
Naouel El Asri, Director Pharma Services , HalioDx
Date: Tuesday March 10th 2020
Time: 9:00am – 12:00pm ET
Le Méridien Boston Cambridge
Meeting room: Robert R. Taylor Room
Cambridge - MIT
20 Sidney Street, Cambridge, MA 02139 USA
A Continental Breakfast buffet will be served at the beginning of the seminar